Ph.D. Paul A. Wagner - 11 Dec 2023 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Role
CEO, Secretary and Chair of the Board, Director
Signature
/s/ Paul A. Wagner, Ph.D.
Issuer symbol
FBRX
Transactions as of
11 Dec 2023
Net transactions value
+$19,276
Form type
4
Filing time
12 Dec 2023, 19:30:27 UTC
Previous filing
08 Dec 2023
Next filing
15 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FBRX Common Stock Purchase $16,188 +25,000 +1.4% $0.6475 1,787,940 11 Dec 2023 Direct F1
transaction FBRX Common Stock Purchase $3,088 +4,776 +0.27% $0.6466 1,792,716 12 Dec 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 25,000 shares purchased in the price range of $0.6199 to $0.65 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average share price of an aggregate total of 4,776 shares purchased in the price range of $0.639 to $0.65 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Remarks:

CEO, Secretary and Chair of the Board